日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Heat Shock Protein 70 Constitutes a Promising Novel Biomarker in Differential Diagnosis between Takotsubo Syndrome and Non-ST-Segment Elevation Myocardial Infarction

热休克蛋白 70 是一种有前途的新型生物标志物,可用于鉴别诊断 Takotsubo 综合征和非 ST 段抬高型心肌梗死

Ozan Demirel, Vera Paar, Philipp Tolnai, Albert Topf, Uta C Hoppe, Michael Lichtenauer, Moritz Mirna

Novel Biomarkers as Potential Predictors of Decompensated Advanced Chronic Heart Failure-Single Center Study

新型生物标志物作为失代偿性晚期慢性心力衰竭的潜在预测指标——单中心研究

Tobias Fröhling, Dilvin Semo, Moritz Mirna, Vera Paar, Zornitsa Shomanova, Lukas J Motloch, Andreas Rukosujew, Jürgen R Sindermann, Michael Lichtenauer, Rudin Pistulli

Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation

髓过氧化物酶和 N 端心房利钠肽作为接受重复消融的患者心房颤动复发的预测指标

Marwin Bannehr, Christian Georgi, Christoph Edlinger, Vera Paar, Paulina Jankowska, Michael Lichtenauer, Anja Haase-Fielitz, Martin Seifert, Christian Butter

Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective

胰岛素样生长因子结合蛋白 2 在重度主动脉瓣狭窄和肺动脉高压中的作用:基于性别的视角

Elke Boxhammer, Vera Paar, Kristen Kopp, Sarah X Gharibeh, Evelyn Bovenkamp-Aberger, Richard Rezar, Michael Lichtenauer, Uta C Hoppe, Moritz Mirna

Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy

肥厚型心肌病的特征是线粒体钙单向转运复合蛋白的改变:从主动脉瓣狭窄患者与肥厚型阻塞性心肌病患者的角度看问题

Vera Paar #, Michael Haslinger #, Philipp Krombholz-Reindl, Stefan Pittner, Matthias Neuner, Peter Jirak, Tobias Kolbitsch, Bernd Minnich, Falk Schrödl, Alexandra Kaser-Eichberger, Kristen Kopp, Andreas Koller, Clemens Steinwender, Michael Lichtenauer, Fabio C Monticelli, Rainald Seitelberger, Uta C

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine

血管紧张素受体-脑啡肽抑制剂 (ARNI) 对葡萄糖和脂肪代谢生物标志物瘦素和果糖胺的影响

Bernhard Ohnewein, Zornitsa Shomanova, Vera Paar, Albert Topf, Peter Jirak, Lukas Fiedler, Christina Granitz, Vincent Van Almsick, Dilvin Semo, Naufal Zagidullin, Anna-Maria Dieplinger, Juergen Sindermann, Holger Reinecke, Uta C Hoppe, Rudin Pistulli, Lukas J Motloch

Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure-A Prospective Observational Study

可溶性致瘤性抑制 2 (sST2) 在以失代偿性右心衰竭为主的患者中的应用——一项前瞻性观察研究

Victoria Dworok, Valentin Hähnel, Marwin Bannehr, Vera Paar, Christoph Edlinger, Michael Lichtenauer, Christian Butter, Anja Haase-Fielitz

sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research

sST2 水平与无症状患者的幽门螺杆菌感染无关:对生物标志物研究的启示

Sarah Wernly, Vera Paar, Andreas Völkerer, Georg Semmler, Christian Datz, Michael Lichtenauer, Bernhard Wernly

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest

无细胞双链 DNA 与 DNase 比率可预测原发性心脏骤停后存活的结果

Richard Rezar, Michael Lichtenauer, Vera Paar, Adrienne Aszlan, Thomas M Hofbauer, Reinhard Kaufmann, Sarah Wernly, Clemens Seelmaier, Moritz Mirna, Andreas Mangold, Irene M Lang, Uta C Hoppe, Anna S Ondracek, Bernhard Wernly

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome

特定心血管生物标志物对 Takotsubo 综合征的鉴别诊断价值

Albert Topf, Moritz Mirna, Vera Paar, Lukas J Motloch, Janine Grueninger, Christiane Dienhart, Paul C Schulze, Mathias C Brandt, Robert Larbig, Uta C Hoppe, Daniel Kretzschmar, Michael Lichtenauer